The mission of the UF Health Division of Pediatric Endocrinology is to improve the lives of children and families affected by diabetes and endocrine disorders.

Our research team is dedicated to achieving this goal through research efforts that that span basic science, animal studies, and clinical trials. Our team is internationally recognized for its exceptional contributions to improving our understanding of the natural history of type 1 diabetes, developing strategies to prevent and reverse the disease, the use of artificial pancreas technologies, and the use of novel ways to educate patients and providers in diabetes management.  In addition, our group is internationally known for expertise and development of novel treatments for Prader-Willi Syndrome.

Type 1 Diabetes

The UF Diabetes Institute offers many studies encompassing a wide range of disciplines and specialties related to the physiology, pathogenesis and treatment of diabetes, as well as its complications, and translation of new knowledge to the clinic and the community. Learn more about clinical trials and research studies currently available by clicking the button below.

Prader-Willi Syndrome

UF Health Endocrinology’s Prader-Willi Research Program is lead by Dr. Jennifer Miller.